Literature DB >> 2849330

Persistent asthma due to isocyanates. A follow-up study of subjects with occupational asthma due to toluene diisocyanate (TDI).

C E Mapp1, P C Corona, N De Marzo, L Fabbri.   

Abstract

Thirty-five subjects with occupational asthma due to toluene diisocyanate (TDI) exposure were examined. All the subjects were studied with inhalation challenges with TDI and with methacholine. TDI asthma was documented by a positive inhalation challenge to low levels of TDI. Airway responsiveness to methacholine was in the range of asthmatic patients at the time of diagnosis. After an average follow-up interval of 10 months, all the subjects were re-examined. Of the 35 subjects examined, 30 subjects (85.7%) left the workplace, and 5 remained in the same job. Twenty-seven subjects (77.1%) continued to have asthmatic attacks requiring medication for relief of symptoms. At follow-up examination, TDI asthma was documented by a positive inhalation challenge to TDI in 27 subjects. Of these 27 TDI reactors, 22 subjects were removed from occupational exposure to TDI. The TDI reactors had persistent respiratory symptoms and airway hyperresponsiveness to methacholine. At follow-up visit, 8 subjects (22.9%) lost sensitization to TDI; 5 subjects (62.5%) in this group had also normal airway responsiveness to methacholine after removal from exposure. Only 1 subject among the TDI nonreactors complained of mild respiratory symptoms. At diagnosis, there were no significant differences between subjects who recovered and those who did not with regard to age, smoking habits, atopy, duration of exposure to isocyanates, duration of symptoms, baseline FEV1 (% pred), and baseline airway responsiveness to methacholine.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2849330     DOI: 10.1164/ajrccm/137.6.1326

Source DB:  PubMed          Journal:  Am Rev Respir Dis        ISSN: 0003-0805


  19 in total

1.  Supermarket baker's asthma: how accurate is routine health surveillance?

Authors:  A Brant; S Nightingale; J Berriman; C Sharp; J Welch; A J Newman Taylor; P Cullinan
Journal:  Occup Environ Med       Date:  2005-06       Impact factor: 4.402

2.  Surveillance for isocyanate asthma: a model based cost effectiveness analysis.

Authors:  D M Wild; C A Redlich; A D Paltiel
Journal:  Occup Environ Med       Date:  2005-11       Impact factor: 4.402

3.  Isocyanates, polyurethane paints, and asthma.

Authors:  J Balmes; S J London; J M Peters
Journal:  West J Med       Date:  1990-02

4.  Longitudinal decline in lung function in patients with occupational asthma due to western red cedar.

Authors:  F J Lin; H Dimich-Ward; M Chan-Yeung
Journal:  Occup Environ Med       Date:  1996-11       Impact factor: 4.402

Review 5.  Occupational asthma due to isocyanates.

Authors:  X Baur
Journal:  Lung       Date:  1996       Impact factor: 2.584

6.  Increase in non-specific bronchial hyperresponsiveness as an early marker of bronchial response to occupational agents during specific inhalation challenges.

Authors:  O Vandenplas; J P Delwiche; J Jamart; R Van de Weyer
Journal:  Thorax       Date:  1996-05       Impact factor: 9.139

Review 7.  Outcome of occupational asthma after cessation of exposure: a systematic review.

Authors:  George Rachiotis; Rashna Savani; Andrew Brant; Stephanie J MacNeill; Anthony Newman Taylor; Paul Cullinan
Journal:  Thorax       Date:  2006-10-13       Impact factor: 9.139

Review 8.  Evidence based guidelines for the prevention, identification, and management of occupational asthma.

Authors:  P J Nicholson; P Cullinan; A J Newman Taylor; P S Burge; C Boyle
Journal:  Occup Environ Med       Date:  2005-05       Impact factor: 4.402

9.  Occupational asthma and extrinsic alveolitis due to isocyanates: current status and perspectives.

Authors:  O Vandenplas; J L Malo; M Saetta; C E Mapp; L M Fabbri
Journal:  Br J Ind Med       Date:  1993-03

10.  Occupational asthma due to soft corrosive soldering fluxes containing zinc chloride and ammonium chloride.

Authors:  D C Weir; A S Robertson; S Jones; P S Burge
Journal:  Thorax       Date:  1989-03       Impact factor: 9.139

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.